You're contacting media contact of this press release
Title: BeachBelleFitness.com Highlights CoreAge Rx NAD+ Injectable Therapy as a Modern Approach to Cellular Energy, Cognitive Support, and Healthy Aging
Wichita Falls, TX, United States, 8th May 2026 - BeachBelleFitness.com has published a new feature article exploring the growing interest in NAD+ injectable therapy and its role in supporting cellular energy, cognitive performance, metabolic efficiency, and healthy aging. The article presents CoreAge Rx NAD+ Injectable Therapy as a comprehensive solution for individuals seeking science-driven wellness support through a streamlined digital healthcare experience.As longevity-focused healthcare continues to evolve, more individuals are turning their attention toward therapies that address wellness at the cellular level rather than simply managing surface-level symptoms. The newly published article examines how NAD+ injectable therapy is emerging as part of a broader “brain + body energy protocol” designed to support energy production, mental clarity, and long-term physiological resilience.According to the feature, NAD+ (Nicotinamide Adenine Dinucleotide) is a naturally occurring coenzyme found in every cell of the human body. It plays a central role in mitochondrial function, DNA repair, metabolic regulation, and overall cellular maintenance. However, natural NAD+ levels gradually decline with age, a process often associated with fatigue, cognitive slowdown, inflammation, and reduced metabolic efficiency.The article explains that CoreAge Rx offers NAD+ injectable therapy through intramuscular or subcutaneous administration, allowing for rapid absorption and systemic support. By delivering NAD+ directly into the body, the therapy is designed to support multiple biological pathways tied to energy production, neurological function, and healthy aging.BeachBelleFitness.com highlights that one of the primary mechanisms behind NAD+ therapy involves mitochondrial performance and A...
This press release is issued by King Newswire